drugset / Trial / NCT00801463
Prednisone Plus Tripterygium Wilfordii Treatment of Adult Patients With Idiopathic Focal Segmental Glomerulosclerosis
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the efficacy of prednisone and tripterygium wilfordii in treated Focal Segmental Glomerulosclerosis (FSGS).
Timeline
- Start
- 2009-01
- Primary completion
- 2011-01
- Completion
- 2011-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | tripterygium wilfordii | Traditional medicine (herbal / TCM) | 120 mg | Oral |